USD26.70
https://www.seyecosmetic.com/manus-storage/ct1_how_img_00_7560ba78.webp The related Athira compound fosgonimeton failed its Phase 2 Alzheimer's trial (LIFT-AD) in 2023 for efficacy, and Athira discontinued development mg:100 Localized fat Cagrilintide (10mg) - Your Peptide Brand
USD26.70
USD28.65
USD28.86
USD20.07
USD27.20
USD26.87
USD23.18
USD24.23
USD20.56
USD26.67